Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens

Alice Limonciel, Simone G. van Breda, Xiaoqi Jiang, Gregory D. Tredwell, Anja Wilmes, Lydia Aschauer, Alexandros P. Siskos, Agapios Sachinidis, Hector C. Keun, Annette Kopp-Schneider, Theo M. de Kok, Jos C. S. Kleinjans, Paul Jennings

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number558
Number of pages15
JournalFrontiers in Genetics
Volume9
DOIs
Publication statusPublished - 3 Dec 2018

Keywords

  • recovery
  • persistence
  • epigenomics
  • stress responses
  • ochratoxin A
  • potassium bromate
  • nephrotoxicity
  • metabolomics
  • OCHRATOXIN-A
  • POTASSIUM BROMATE
  • INDUCED CYTOTOXICITY
  • OXIDATIVE STRESS
  • FOOD-ADDITIVES
  • DNA-DAMAGE
  • IN-VITRO
  • TOXICITY
  • KIDNEY
  • RAT

Cite this

Limonciel, A., van Breda, S. G., Jiang, X., Tredwell, G. D., Wilmes, A., Aschauer, L., Siskos, A. P., Sachinidis, A., Keun, H. C., Kopp-Schneider, A., de Kok, T. M., Kleinjans, J. C. S., & Jennings, P. (2018). Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens. Frontiers in Genetics, 9, [558]. https://doi.org/10.3389/fgene.2018.00558